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Summary
In a randomised, double-blind prospective study we compared the effects on postoperative pain
and analgesic consumption of intra-operative s(+)-ketamine (100 pg.kg-t bolus and a conrinuous
infusion of 2 pg.kg 1.nnn-l) followed by postoperative patient-controlled analgesia with morphine
(1 mg per bolus) plus s(+)-ketamine (0.5 mg per bolus), or intra-operacive saline followed by
postoperative patient-controlled analgesia morphine (1 mg per bolus) alone. A total of 28 male
patients undergoing radical prostatectomy were studied. Morphine consumption, pain scores,
pressure algometry and adverse effects were recorded for 48 h after surgery. Cumulative morphine
consumption was significantly lower in the ketamine,/morphine group (47.9 + 26.2 mg) than in
the saline,/morphine group (73.4 + 34.8 mg; p = 0.049). Pain scores at rest were significandy
lower in the ketamine,/morphine group across the 48-h study period (p = 0.01). No significant
di{ferences were found in pressure algometry measurements or the occurrence of adverse effects.
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There is a large body ofevidence indicating that noxious
stimulation and frank injury may have profound effects on
the central neural processes involved in pain transmission,
including the establishment of central sensitisation and the
transition of acute, time-limited pain to chronic, patho-
logical pain ft, 2]. lt is now well established that the
N-methyl-o-aspartate (NMDA) receptor-ion channel
complex plays a critical role in the development of
central sensitisation [3, 4]. This has led to renewed
interest in the pain-relieving properties of clinically
available NMDA receptor antagonists such as ketamine
[5] for use in humans undergoing major surgery.
More recently, NMDA receptor activation has also
been linked to the development of acute opioid tolerance
and opioid-induced hyperalgesia [6, 7]. Furthermore it is
now recognised that the process of central sensitisation is
induced not only during surgery but also postoperatively
by inflammatory injuries [8, 9]. In the clinical seting this
suggests that for optimal e{fect, NMDA receptor antag-
onists need to be administrated before induction of
anaesthesia @efore the opioids are given) and continued
during surgery and well into the postoperative period. To
evaluate this possibility we compared the effects of intra-
operative low dose s(+)-ketamine vs. saline given intra-
venously (started before induction of anaesthesia)
followed by intraverous p ostop erative patient-c ontrolled
low dose s(+)-ketamine plus morphine, vs. morphine
alone, on postoperative pain and analgesic consumption
aft er radical prostatectomy.
Methods
Approval to carry out the study was obtained ftom the
institutional ethics committee at the Universiry Medical
Centre, Nijmegen. Eligible patients were men scheduled
for radical retropubic prostatectomy. Inclusion criteria
were abfity to speak Dutch, 18-75 years of age, ASA
class 1-3, stable or no significant central nervous system,
respiratory, cardiac, hepatic, renal or endocrine dysfunc-
tton and/or any significant sequelae, no history of
significant psychopathology, chronic pain or chronic use
of opioid or non-opioid analgesics, no previous allergies
or adverse reactions to opioid analgesics, no ingestion of
antitussive medication (dextromethorphan) within 48 h
of surgery, no history of alcohol or drug dependency or
abuse, and body weight 60-100 kg with a body mass
index S 30 kg.m-2.
All patients were told about the study and screened for
suitability and interest during the visit to the Preoperative
Assessment Clinic approximately 2-4 weeks before sur-
gery. At that time patients were informed about the
nature and purpose of the study and were sent home with
a consent form describing the study purpose, procedures
and risks. One week later, the patient was telephoned at
home to answer any questions and to obtain verbal
informed consent. On the day before surgery, after
admission to the hospital, patients who had verbally
consented were visited on the ward to obtain written,
informed consent. Patients were then introduced to the
Visual Analogue Scale (VAS), the patient-controlled
analgesia (PCA) pump, and pressure algometry. A base-
line VAS pain score was taken with the patient in a resting
position. On the day before surgery, patients were
randomly assigned to one of tlvo groups: ketamrne,/
morphine or saline,/morphine. Two syringes were
prepared for each patient; one contained either 50 ml
s(+)-ketamine I mg.mJ-r or saline for intra-operative
administration and the other 50 ml s(+)-ketamine
1 mg.nil-l plus morphine 2 rng.rril-l or morphine
2 mgrri-' alone for postoperative use in the PCA pump.
Study syringes were prepared and dispensed by the
Pharmacy of the lJniversity Medical Centre Nljmegen on
the basis of a predetermined randomisation schedule
(using the random function of Microsoft nxcnr 97). The
syringes were coded and prepared in a blinded fishion for
each patient and retained by the pharmacy department.
Premedication consisted of oral midazolam 7.5 mg
(administered 45-60 min before the expected time of
induction of general-arnesthesia). An additional 2 mg
midazolam was given intravenously after insertion of a
venous line. Five minutes before induction with propofol
(2 mg.kg-l) and fentanyl (2 Ug.kg-t), patients received a
bolus injection of 0.1 ml.kg-' s(+)-ketamine (keta-
mine,/morphine group) or saline (saline,/morphine group),
followedby a continuous infusion of0.002 mlkg-1.min-1
of the same agent. For patients in the ketamine,/morphine
group, this amounted to a bolus dose of 100 pg.kg-t s(+)-
ketamine and a continuous infusion of 2 pg.kg-t.min-l
s(+)-ketamine. After induction, 0.6 mg.kg-r rocuronium
was given to facilitate tracheal intubation. Anaesthesia was
maintained with isoflurane in N2O,/O2 60%/ 40%) aiming
at an end expiratory concentration of isoflurane of 0.7%.
Further rocuronium 0.1-0.2 mg.kg-l was given when
necessary. Morphine in a dose of 50 pg.kg-r was given
when there were signs of inadequate analgesia (increase
in blood pressure or heart rate above 70% of baseline
value). The continuous infusion of s(+)-ketamine (keta-
mine,/morphine group) or saline (saline,/morphine group)
was stopped at skin closure. At the conclusion of surgery,
neuromuscular blockade was reversed (when necessary)
with neostigmine (0.05 mg.kg-r) and atropine (0.01-
0.02 mg.kg-l).
Immediately on arrival in the Post Anaesthesia Care
Unit the PCA pump (SIMS Graseby 3300 PCA Pump,
Watford, Herts, UK), loaded with the coded syringes, was
attached to the patient's intravenous cannula. The PCA
system was programmed to deliver a bolus of 0.5 ml,
corresponding to a bolus dose of 0.5 mg s(+)-ketamine
plus 1 mg of morphine for the ketamine,/morphine group
and 1 mg morphine for the saline,/morphine group. The
lock-out time was set at 5 min. No background infusion
was delivered. If the patient complained of pain in the
Post Anaesthesia Care Unit but was too drowsy to use the
PCA pump, the attending nurse was permitted to push
the PCA pump button. PCA was continued until the end
of the study, 48 h after surgery. No other analgesics were
administered during the study period. When required,
bladder spasm pain was treated with 5 mg oxyburynin
three times daily. After transfer to the ward, pain
management was supervised by the researchers and the
Acute Pain Service. If a patient required intravenous
analgesia beyond the 48-h study period, the study syringes
were removed and the patient was treated according to
the hospital's Acute Pain Service protocol for managing
pain. Nausea and vomiting were treated with ondansetron
4 mg given intravenously.
Pain was assessed with patients at rest (VAS-R) at 1, 2,
3, 4,8, 12, 18,24,30,36, 42 and 48 h after surgery. The
VAS pain scale consists of a 10-cm horizontal line with
the two endpoints labelled 'no [ain' and 'worst possible
pain'. Pain was also assessed after standard mobilisation
(VAS-M) at 24 and 48 h by xlo.ng patients to perform
two maximal inspirations before rating their pain. Sen-
sitivity to mechanical pressure around the surgical wound
was assessed using a Pressure Threshold Meter (Pain
Diagnostics and Thermography Inc., Great Neck, NY), a
force gauge with a rubber tip (1 cm2 in diameter) and a
10-kg range in 0.1-kg divisions. The pain perception
threshold was determined by applying pressure and
recording in kg.cm-2 the level at which the patient first
reported pain. The patient then rated, on a L0-cm VAS,
the intensity of the pain at this threshold. After surgery,
pain perception thresholds were obtained 5 cm from the
le{t and right edges of the surgical wound (halfway
between umbilicus and pubic symphysis) at 24 and 48 h
after surgery.
Subjective reports of dreams (0 = none, I = pleasant,
2 = unpleasant, 3 = nightmare), hallucinations (0 = no,
1 
- 
y"r) and other adverse effects were documented for
all patients at 24 rnd 48 h after surgery. The latter e$ects
included drowsiness, dizziness, confusion and feelings
of unreality (0=none, 1=mild, 2=moderate, 3=
severe). Postoperative sedation was assessed 
^t I, 2, 3, 4,8, 12, 18, 24, 30, 36, 42 and 48 h after surgery using a
5-point modified sedation scale (0 = alert and orientated,
1 = awake but drowsy, 2 = sleeping but arousable by
verbal commands, 3 = sleeping but arousable by tactile
stimuli, and 4 = comatose) [10]. Postoperative nausea and
vomiting were assessed at I,2,3, 4,8, 72, L8,24,30,36,
42 and 48 h after surgery. Nausea was measured using a
10-cm horizontal VAS with endpoints labelled 'no
nausea' and 'extreme nausea'. Vomiting was assessed as
present or absent. Postoperative pruritus was assessed at 1,
2, 3, 4, 8, 12, 78, 24, 30, 36, 42 and 48 h after surgery
using a 10-cm horizontal VAS with endpoints labelled'no
itching' and 'extreme itching'.
Before the start of the study we estimated that a total
sample size of 22 pa;tients would be required (11 per
group). This was based on a type-I error rate of 0.05 and
power of 0.90, using 48-h mean cumulative morphine
consumption used by patients in the study by Adriaens-
sens et al. [11], with ability to detect a mean difference of
-27 mE Q7 mg vs. 54 mg) with a standard deviation of
20 mg. Based on an anticipated attrition rate of 20-25%
due to prerandomisation drop-outs, complications,
adverse effects, protocol violations, and withdrawals, a
total of 28 patients were recruited. Data were analysed
using the Statistical Package for the Social Sciences (srss
for wINoows, release 10.0, Chicago, IL). Clinical
variables and cumulative morphine consumption were
compared using independent t-tests for continuous data
and Fisher's exact test for categorical data. The primary
outcome measure, cumulative morpliin6 consumption at
48 h after surgery, was compared by independent samples
r-test. The VAS-R pain scores at ser-rntervals (see above)
and PCA molphine consumption betlyeen these intervals
were each analysed by rwo-way repeated measures ANovA
using group as the independent samples factor and time as
the repeated measures factor. Area under the curve was
also computed for the rr,vo groups for morphine con-
sumption and VAS-R pain scores and compared befween
the groups by independent samples l-test [12]. Visual
analogue pain scores on movement (VAS-M), pressure
pain threshold and magnitude of side-effects were ana-
lysed by Mann-\Vhitney U-test, and incidence of adverse
effects by Chi-squared test. Statistical significance was set
at p < 0.05. No intent-to-treat analysis was planned; only
a per protocol analysis was performed.
Results
Of the 28 patients enrolled in the study, three were
excluded: one in the ketamine,/morphine group because
of protocol violation on the first postoperative day (he
was given a sedative by the attending urologist) and two
in the saline/morphine group (one because of surgery
lasting > 6 h with the need for postoperative ventilation,
and another because of development of a large wound
haematoma on the first postoperative day). Baseline
characteristics and clinical variables are shown in Table 1.
Although mean end-expiratory isoflurane concentration
Table 1 Baseline and pre- and intra-operative data in patients
receiving ketamine,/morphine or saline,/morphine. Values are
as mean (SD).
Ketamine/
morphine
(n 
= 13)
Saline/
morphine
(n 
= 12)
Age; years
Weight; k9
Height; cm
Preoperative VAS*
for pain; cm
Total intra-operative
morphine; mg
Mean end-expiratory
isoflurane concentration; %
Blood loss; ml
Duration of surgery min
60.1 (4.7)
83.1 (13.6)
179 (s.8)
0.0 (0.0)
8.s (6.3)
0.6s (0.07)r
1472 (752)
148 (23)
61.7 (4.7)
79.9 (12.2)
180 (8.3)
0.0 (0.0)
10.0 (6.1)
0.71 (0.04)r
r s1 8 (8s6)
1 s8 (2s)
*VAS; visual analogue scale.
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Figure 1 Cumulative PCA-morphine
consumption in patients receiving
ketamine,/morphine (solid) or saline,/
morphine (clear). Values are mean (SD).
Overall consumption was less in the
ketamine/morphine group than in the
saline./morphine group (p = 0.049).
differed significantly berween the groups this was not
considered clinically siglificant.
Mean (SD) total cumulative morphine consumption
was sigrificantly lower (p = 0.049) in the ketamine/mor
phine group (47.9 mg + 26.2 mg) compared with the
saline,/morphine group (73.4 mg t 34.8 mg) at the end
of the study, 48 h after surgery; cumulative consumption
over time is shown in Fig. 1. Results of the ANovA
indicated that over the 48-h study period patients in the
ketamine,/morphine group consistendy self-administered
significantly less morphine (p = 0.049) than those in the
saline./morphine group and consistent with this, the area
under the curve for morphine in the ketamine,/morphine
group was also less (p = 0.037). Pain scores at rest
analysed by ar.rova and by comparison of area under the
curve also revealed sigrificant di{ferences berween the
groups (Table 2). Significant differences were not found
for VAS-M pain scores (Table 2), nor for the number of
patients needing oxyburynin for bladder spasm pain or
pressure pain thresholds at 24 or 48 h after surgery
(Table 3).
No significant differences were found in the incidence
or extent of morphine or s(+)-ketamine-related side-
effects. No hallucinations were reported at any time
point. One patient in each group reported 'pleasant'
dreams at24 h, but no dreams were reported at 48 h. All
other side-effects are presented in Table 4.
Discussion
The results of this study show that low-dose s(+)-
ketamine given during and after radical prostatectomy
reduces PCA morphine consumption by 34% at 48 h
after surgery and lower pain scores at rest compared with
a standard treatment control group that did not receive
s(+)-ketamine.
Ketamine belongs to the group of non-competitive
NMDA receptor antagonists that bind to the phenylcyc-
lidine recognition site in the NMDA receptor-operated
ion channel [13]. Although there is evidence for the
Table 2 Postoperative pain scores at rest (VAS-R) and
standard mobilisation (VAS-M) in patients receiving
amine,/morphine or saline,/morphine. Data are mean
[range]).
after
ket-
(SD
Ketamine/
morphine
(n 
= 13)
Saline/
morphine
(n 
= 12) p-value
VAS-R; cm
th
2h
3h
4h
8h
12h
18h
24h
30h
Jbn
42h
48h
Area under
the curvet
VAS-M; cm
24h
48h
3.3 (1.5 [0.9-6.1])
2.4 (r.8 [0-s.8])
1.7 (1.2 [o-3.8])
1.4 (1.2 t0-2.91)
1.8 (1.4 [0-4.9])
1.2 (1,2 [0-4.0])
1.s (1.4 t0-4.81)
1.2 (1.0 t0-3.11)
1.6 (2.2 [o-8.6])
0.6 (0.8 [o-2.0])
1.1 (1.9 [0-s.o])
0.8 (0.8 [0-2.5])
61.2 (2s.2 [7.s-1oe])
2.7 (2.st0.0-7.31)
1.1 (1.2[o-3.7])
4.9 (1.s 12.7-8.41) o.ol *
4.2 (1.8 [0.8-6.91)
3.3 (1.4 t1.3-6.11)
2.9 (1.6 [0.8-s.s])
2.2(1.3 10-4.01)
2.1 (1.s to-s.ol)
2.8 (1.2 [1.3-4.81)
2.0 (1.4 [o-5.4D
1.8 (2.0 t0-6.81)
1.s (1.4 [0-s.0])
1.4 (1.3 tH.ol)
0.e (0.8 to-z.11)
92.4 (M.9 142.2-204.81) 0.04e
2.8 (2.6[0.0-e.0]) NS
0.s (0.410-1,11) Ns
*For ANovA across whole 48-h study period.
tArea under the curve for VAS-R 1-48 h.
interaction of ketamine with opioid receptors, monoam-
inergic receptors, nicotinic and muscarinic cholinergic
receptors, Ca2* channels, GABA receptors and Na*
channels I1,4,15], ketamine has the highest affiniry for the
NMDA receptor. Ketamine is a racemic mixture of two
enantiomers, s(+) and r(-) ketamine. S(+)-ketamine
shows an afiiniry for the NMDA receptor that is four
times higher than that of r(J-ketamine [16]. In a study of
healthy volunteers, ketamine isomers induced less fatigue
and cognitive impairment than equianalgesic low-dose
racemic ketamine. In addition, s(+)-ketamine produced
less of a decline in concentration capacity and primary
memory [17]. Because of its higher potency (about
twice that of racemic ketamine) and more favourable
Table 3 Need for oxybutynin for bladder spasm pain, and
'pressure pain thresholds (PPT) at 24 tnd 48 h after surgery, in
patients receiving ketamine,/morphine or saline,/morphine.
-Values are number (proportion) or mean (SD [range]). No
significant differences betvyeen groups.
it has been shown that opioids activate not only
antinociceptive systems but also pronociceptive systelru,
causing acute opioid tolerance and opioid-induced
hyperalgesia [6, 7]. These phenomena seem to stem from
a common NMDA receptor-dependent mechanism; use
of p:opioid receptor agonists causes a sustained increase in
NMDA-activated currents by activating intracellular
protein kinase C. In tum, protein kinase C potentiates
the NMDA response by reducing the voltage-dependent
Mg2* block of NMDA-receptor channels [18]. In rats,
pretreatment with ketamine (before opioid administra-
tion) and subsequent repeated ketamine injections pre-
vented opioid-induced hyperalgesia and acute tolerance
to opioids [19]. Second, it is now recognised that central
sensitisation is not only induced during surgery by
incisional injury but also postoperatively by inflammatory
injuries [8, 9]. This means that efforts to prevent the
development of central sensitisation must be continued
well into the postoperative period and should not be
Iimited to the duration of the surgical procedure. The
practical consequences ofboth ofthese concepts are that
ketamine should be administered before induction of
Ketamine/morphine
(n 
= 13)
Saline/morphine
(n 
= 121
Oxybutynin required
24h
48h
1(8%)
1(8%)
0
1 (8o/o)
1.2 (0.6 [0.1-2.2])
2.0 (o.e [0.2-4.7])
3.e (2.3 [0.4-8.0])
4.2 (2.6 [0.1-8.9])
PPT; kg.cm-2
24h 1.7 (1.2 tH.ol)
€ 
h 1.s (0.7 [o.s-3.2])
VAS* at PPT; cm
4.e (1.8 [2.2-7 .71')
4.5 (2.4 [0.3-€.6D
24h
48h
Drowsiness*
24h 1/4/7/1
48 h 4/s/3/1
Dizziness*
24 h 10/2/1,/0
48 h a/4/1/O
Confusion*
24h 11/1/1/0
48h
Feelings of unreality"
13/0/0/0
12/1 /0/0
11 /2/O/O
13/0/O/O/0
12/0/1 /O/O
1.1 (2.1 [H.90
0.1 (0.4 [0-1.40
o (o [o-0.1D
0,1 (0.3 I0-1.21)
1 /4/6/1
s/6/1 /0
12/O/O/0
9/3 /0/0
10/1 /1 /0
11 /1 /0/0
10/2,/O/O
12/0/O/0
11 /1 /0/0/O
12/O/O/0/0
0.4 (0.6 [o-2.0])
0.4 (1,0 [(F3.6])
1 /11
1 /11
o (o to-0.11)
0.1 (0.3 t0-1.01)
*VAS; visual analogue scale.
Table 4 Advene efects in patients receiving ketamine./
morphine or saline/morphine. Values are number or mean (SD
[range]). No significant diferences befween groups.
Ketamine/morphine
(n 
= 13)
saline/morphine anaesthesia (especially before the opioids are given) and
(n 
= 12) continued during surgery and into the postoperative
period. As suggested by the results of the present study,
this leads to lower postoperative morphine consumption
and also to lower postoperative pain scores. Further study
is required to ascertain the practical importance, in the
clinical setting, of the need to give ketamine before the
opioids, by comparing the administration of ketamine
before and after the opioids.
'We did not find significant differences in the sensitiviry
to mechanical pressure applied around the surgical
wound. Tverskoy et al. [20] used pressure algometry on
the wound to show that the use of a rather high dose
of racemic ketamine (bolus dose of 2 mg.kg-1 during
induction followed by a continuous infusion of
20 pg.kg-1.min-1 until the end of surgery) decreased
wound sensitiviry in patients after abdominal hysterec-
tomy. Kopert et aI. [21] used von Frey filaments to show
that a mean dose of 0.4 mg.kg-' of s(+)-ketamine
(administered over 20 min) was capable of inhibiting
the development of secondary hyperalgesia in experi-
mentally electrically induced pain. The use of higher
doses of s(+)-ketamine might have yielded more signi-
ficant differences in sensitivity to mechanical pressure
around the surgical wound in the present study.
To date only one other published study has described
the use of intravenously given low-dose s(+)-ketamine in
the surgical patient. In contrast to the results of the
present study, Jaksch et al. l22l did not find evidence for
improved postoperative analgesia when s(+)-ketamine
was used in patients undergoing arthroscopic anterior
24h
48h
Sedationt
24h
48h
Nausea VAS; cm
24h
48h
Vomiting; Y,/N
24 h 0/13
48 h 0/13
Pruritus VAS; cm
24h
48h
* N one,/ m i I d,/ moderate,/severe
tAlert and orientated/awake but drowsy,zsleeping but rousable by
verbal commands,/sleeping but rousable by tactile stimuli,/comatose.
adverse-effects profile, s(+)-ketamine is an attractive alter-
native to the racemate for peri-operative use in humans.
For low-dose ketamine to be an eflective (co)analgesic
and morphine-sparing agent in the surgical patient, trvo
recently evolved concepts are of major importance. First,
cnrciate ligament repair. There are three obvious differ-
ences betrveen our study and that ofJaksch et al.: starting
the s(+)-ketamine after opioids were given; discontinu-
ation of s(+)-Fetamine 2 h {ter surgery; and the type of
surgery. As discussed, the fint differences can possibly lead
to a reduced--effectiveness of low-dose s(+)-ketamine.
Most importandy, the study byJaksch et al. examined the
effect of peri-operative s(+)-ketamine on later postoper-
ative pain since they stopped the ketamine infusion 2 h
after surgery but continued to look for e{Fects over the
following 5 days. In contrast, we examined the effect on
postoperative use of morphine and postoperative pain of
starting a low dose of s(+)-ketamine before induction
with continuation during surgery and for 48 h thereafter.
Another difference betlveen studies concems the patient
populations and surgical procedures. Compared with the
major surgery (radical prostatectomy) in the present study,
the arthroscopic knee surgery used in the study ofJaksch
et al. is a relatively minor type of surgery. It is clear that
arthroscopic surgery causes less tissue trauma, which may
lead to a lower postoperative pain intensiry. Finally,
patients in the study by Jaksch et al. were substantially
younger (30 (8) years and 33 (7) year$ than the patients in
the present study (60 (4.7) yean and 6t.2 (4.7) year$.
This raises the possibility that the opioid-sparing effects of
s(+)-ketamine nuy be age related; however, further
research is required to evaluate this possibiliry.
There are several limitations to the present study.
The first concerns the relatively small number of
patients studied. This might explain why, despite the
34Yo rcduction in 48-h morphine consumption in the
ketamine,/morphine group, no differences in morphine
related side-e{fects were found. Second, patients in this
study were only followed up to 48 h after surgery. The
study cannot address the question of whether peri-
operative s(+)-ketamine influences pain and analgesic
consumption in the longer terrn. Third, although we
did not find differences in psychomimetic side-effects, a
larger study is needed to assess this properly. A larger
study is also needed to assess whether the favourable
postoperative effects of s(+)-ketamine make a difference
in clinical outcomes such as time to ambulation,
resumption of dietary intake and discharge from
hosoital.
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